Straiker A et al. |
Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. |
2012 |
Br. J. Pharmacol. |
pmid:22014238
|
Hillard CJ et al. |
Inhibition of 2-arachidonoylglycerol catabolism modulates vasoconstriction of rat middle cerebral artery by the thromboxane mimetic, U-46619. |
2007 |
Br. J. Pharmacol. |
pmid:17891162
|
Lau BK et al. |
Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. |
2014 |
Br. J. Pharmacol. |
pmid:25041240
|
Rimmerman N et al. |
Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line. |
2008 |
Br. J. Pharmacol. |
pmid:17965731
|
Hohmann AG |
Inhibitors of monoacylglycerol lipase as novel analgesics. |
2007 |
Br. J. Pharmacol. |
pmid:17293886
|
Chicca A et al. |
The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors. |
2012 |
Br. J. Pharmacol. |
pmid:22646533
|
Lépicier P et al. |
Endocannabinoids protect the rat isolated heart against ischaemia. |
2003 |
Br. J. Pharmacol. |
pmid:12813004
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Mukhopadhyay P et al. |
CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. |
2010 |
Br. J. Pharmacol. |
pmid:20590569
|
Liao HT et al. |
Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition. |
2011 |
Br. J. Pharmacol. |
pmid:21232043
|
Bisogno T et al. |
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. |
2013 |
Br. J. Pharmacol. |
pmid:23072382
|
Murataeva N et al. |
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS. |
2014 |
Br. J. Pharmacol. |
pmid:24102242
|
Ghafouri N et al. |
Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. |
2004 |
Br. J. Pharmacol. |
pmid:15492019
|
Soria-Gómez E et al. |
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. |
2007 |
Br. J. Pharmacol. |
pmid:17549045
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Mulder J et al. |
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. |
2011 |
Brain |
pmid:21459826
|
Doenni VM et al. |
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. |
2016 |
Brain Behav. Immun. |
pmid:27453335
|
Mecha M et al. |
Endocannabinoids drive the acquisition of an alternative phenotype in microglia. |
2015 |
Brain Behav. Immun. |
pmid:26086345
|
Hanus L et al. |
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. |
2003 |
Brain Res. |
pmid:12914975
|
Lourbopoulos A et al. |
Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis. |
2011 |
Brain Res. |
pmid:21406188
|